Literature DB >> 32950704

Trends in the manifestations of 9754 gout patients in a Chinese clinical center: A 10-year observational study.

Qianhui Gao1, Xiaoyu Cheng1, Tony R Merriman2, Can Wang1, Lingling Cui1, Hui Zhang3, Wenyan Sun3, Jing Wang4, Feiyue Wang4, Changgui Li5, Jie Lu6.   

Abstract

OBJECTIVE: The prevalence of gout is increasing but studies of its clinical features in large samples are lacking. This study aimed to clarify changes in the clinical manifestations of gout in China over the last decade and investigate the clinical features and risk factors of early-onset gout.
METHODS: Clinical manifestations were compared between 9754 gout patients who first presented at our clinic with gout in 2008-2012 (earlier group) or 2013-2018 (later group). Gout onset≤30 years old was defined as early-onset and>30 years as late-onset. Clinical features and risk factors were compared between the groups.
RESULTS: The gout-onset age was 4.14 years younger and the percentage of early-onset gout (3827 patients) was higher in the later 2013-2018 group (5979 patients). The disease duration was significantly shorter (5.72±0.09 vs. 6.01±0.11 years P < 0,05) and the ratio of patients with tophi was correspondingly lower in the later group (22.0% vs. 20.0%, P < 0,05). More patients were obese (32.6% vs. 37.7%, P<0.001) and serum urate levels (465.0±1.9μmol/L vs. 485.5±1.5μmol/L) were significantly higher in the later group. As the age of gout-onset became younger, we did the multivariate logistic regression and identified a positive family history, male sex, obesity, elevated serum urate, and sugar-sweetened soft drinks as independent predictors of early-onset gout.
CONCLUSION: The manifestations of gout in China have changed over the last decade, associated with a trend towards younger onset.
Copyright © 2020 Société française de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Early-onset; Gout; Risk factors

Mesh:

Year:  2020        PMID: 32950704     DOI: 10.1016/j.jbspin.2020.09.010

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  5 in total

Review 1.  The Interaction Between Dietary Fructose and Gut Microbiota in Hyperuricemia and Gout.

Authors:  Xin-Yu Fang; Liang-Wei Qi; Hai-Feng Chen; Peng Gao; Qin Zhang; Rui-Xue Leng; Yin-Guang Fan; Bao-Zhu Li; Hai-Feng Pan; Dong-Qing Ye
Journal:  Front Nutr       Date:  2022-06-22

2.  The Clinical Effects of Febuxostat Alone or Combined with Arthroscopic Surgery for Gout: A Single-Center Retrospective Study.

Authors:  Zhen Gong; Li Xia; Rune Xu; Min Luo; Hongxiang Deng; Zhiping Kang; Leping Liu; Yaqing Liu; Fangjie Zhang; Jian Shi
Journal:  J Inflamm Res       Date:  2021-09-07

3.  A machine learning-assisted model for renal urate underexcretion with genetic and clinical variables among Chinese men with gout.

Authors:  Mingshu Sun; Wenyan Sun; Xuetong Zhao; Zhiqiang Li; Nicola Dalbeth; Aichang Ji; Yuwei He; Hongzhu Qu; Guangmin Zheng; Lidan Ma; Jiayi Wang; Yongyong Shi; Xiangdong Fang; Haibing Chen; Tony R Merriman; Changgui Li
Journal:  Arthritis Res Ther       Date:  2022-03-09       Impact factor: 5.156

Review 4.  Dietary and Lifestyle-Centered Approach in Gout Care and Prevention.

Authors:  Chio Yokose; Natalie McCormick; Hyon K Choi
Journal:  Curr Rheumatol Rep       Date:  2021-07-01       Impact factor: 4.686

5.  Effects of fenofibrate therapy on renal function in primary gout patients.

Authors:  Xinde Li; Wenyan Sun; Jie Lu; Yuwei He; Ying Chen; Wei Ren; Lingling Cui; Zhen Liu; Can Wang; Xuefeng Wang; Lidan Ma; Xiaoyu Cheng; Lin Han; Hailong Li; Hui Zhang; Xuan Yuan; Xiaopeng Ji; Aichang Ji; Tony R Merriman; Changgui Li
Journal:  Rheumatology (Oxford)       Date:  2021-11-03       Impact factor: 7.580

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.